LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $24,292,000 | +46.7% | 813,800 | -13.9% | 0.01% | +33.3% |
| Q4 2016 | $16,561,000 | -27.9% | 944,700 | -2.2% | 0.01% | -25.0% |
| Q3 2016 | $22,972,000 | +48.7% | 965,600 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $15,450,000 | -23.5% | 965,600 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $20,191,000 | -22.6% | 965,600 | 0.0% | 0.01% | -15.4% |
| Q4 2015 | $26,071,000 | +2.9% | 965,600 | +5.9% | 0.01% | 0.0% |
| Q3 2015 | $25,342,000 | +5.0% | 911,900 | -7.4% | 0.01% | +18.2% |
| Q2 2015 | $24,133,000 | +43.3% | 984,600 | +7.0% | 0.01% | +37.5% |
| Q1 2015 | $16,843,000 | -0.8% | 920,400 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $16,981,000 | +92.0% | 920,400 | 0.0% | 0.01% | +100.0% |
| Q3 2014 | $8,845,000 | +4.7% | 920,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $8,449,000 | – | 920,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |